ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 107 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2021. The put-call ratio across all filers is 5.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $31,000 | 0.0% | 43,740 | 0.0% | 0.00% | – |
Q4 2022 | $31,000 | -42.6% | 43,740 | +22.4% | 0.00% | – |
Q3 2022 | $54,000 | +50.0% | 35,740 | 0.0% | 0.00% | – |
Q2 2022 | $36,000 | -32.1% | 35,740 | -4.2% | 0.00% | – |
Q1 2022 | $53,000 | -41.8% | 37,302 | +115.6% | 0.00% | – |
Q4 2021 | $91,000 | -7.1% | 17,302 | +2.4% | 0.00% | – |
Q3 2021 | $98,000 | -54.8% | 16,902 | -37.7% | 0.00% | -100.0% |
Q2 2021 | $217,000 | +18.6% | 27,110 | +150.8% | 0.00% | 0.0% |
Q4 2019 | $183,000 | -36.7% | 10,809 | -14.8% | 0.00% | -50.0% |
Q2 2019 | $289,000 | +39.6% | 12,687 | +28.5% | 0.00% | +100.0% |
Q1 2019 | $207,000 | -13.8% | 9,872 | -5.8% | 0.00% | -50.0% |
Q3 2018 | $240,000 | +9.1% | 10,482 | +6.2% | 0.00% | 0.0% |
Q2 2018 | $220,000 | -8.7% | 9,872 | -6.5% | 0.00% | 0.0% |
Q1 2018 | $241,000 | -2.0% | 10,557 | +12.8% | 0.00% | 0.0% |
Q4 2017 | $246,000 | +8.8% | 9,357 | +13.8% | 0.00% | 0.0% |
Q2 2017 | $226,000 | -42.5% | 8,225 | -49.3% | 0.00% | -50.0% |
Q1 2017 | $393,000 | +12.9% | 16,225 | -3.3% | 0.00% | 0.0% |
Q4 2016 | $348,000 | +4.2% | 16,775 | +36.3% | 0.00% | 0.0% |
Q3 2016 | $334,000 | +77.7% | 12,310 | -5.8% | 0.00% | +100.0% |
Q2 2016 | $188,000 | +8.0% | 13,062 | +22.1% | 0.00% | 0.0% |
Q3 2015 | $174,000 | -12.6% | 10,702 | -34.4% | 0.00% | -50.0% |
Q4 2013 | $199,000 | +15.0% | 16,310 | +47.3% | 0.00% | 0.0% |
Q3 2013 | $173,000 | – | 11,070 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 225,239 | $1,295,123 | 1.10% |
CHARTIST INC /CA/ | 67,073 | $385,667 | 0.23% |